Psychiatry and mental health: clinical-trial pipeline
34,014 psychiatry and mental health trials are in ClinicalTrials.gov and the EU CTIS portal; 7,680 are not yet finished and 308 of those are in phase 2/3 or 3. Source: Arcadium Data, data as of .
Open trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 6,382 |
| Phase 2 | 499 |
| Phase 3 | 249 |
| Phase 4 | 210 |
| Phase 1 | 133 |
| Phase 1/2 | 78 |
| Early phase 1 | 70 |
| Phase 2/3 | 59 |
Sponsors with the most open trials
Recently changed open trials
| Registry id | Title | Sponsor | Phase | Status | Countries |
|---|---|---|---|---|---|
| NCT06113471 | A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2) | Incyte Corporation | Phase 3 | Active, not recruiting | Bulgaria, Canada, Germany, France +5 |
| NCT06072183 | A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranq… | Pfizer | Phase 3 | Active, not recruiting | Australia, Belgium, Bulgaria, Canada +13 |
| 2023-509607-32-00 | Lithium versus Lamotrigine in bipolar disorder, type II – a single blinded randomized controlled trial (the L… | Region Hovedstaden | Phase 4 | Recruiting | Denmark |
| 2023-508291-11-00 | Impact of dextroamphetamine substitution on the use of illicit amphetamines in adults with comorbid dependenc… | Helse Bergen HF | Phase 2 | Recruiting | Norway |
| NCT06382389 | Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Sympto… | University Hospital, Tours | Phase 2 | Not yet recruiting | France |
| NCT06113445 | A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1) | Incyte Corporation | Phase 3 | Active, not recruiting | Belgium, Canada, Germany, Spain +6 |
| 2023-508981-13-00 | A Randomized, Multiple-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY0… | Geneora Pharma (Shijiazhuang) Co. Ltd. | Phase 1 | Not yet recruiting | Bulgaria, Croatia, Portugal |
| NCT06833788 | Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression | Assistance Publique - Hôpitaux de Paris | Phase 4 | Recruiting | France |
| 2024-512478-86-00 | Pharmacologic treatment augmentation in chronic depression “randomized, controlled, double blinded, phase II… | Universitaetsklinikum Tuebingen AöR | Phase 2 | Recruiting | Germany |
| NCT06689254 | REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR… | Amsterdam UMC | Phase 2 | Recruiting | Netherlands |
| 2023-508229-28-00 | High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder:… | Arq National Psychotrauma Centre | Phase 2 | Recruiting | Netherlands |
| NCT06163326 | A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitil… | Pfizer | Phase 3 | Not yet recruiting | Australia, Bulgaria, Canada, China +9 |
| 2023-506329-12-00 | Traitement des Idées Suicidaires aux urgences par adjonction de Protoxyde d’Azote (PROTORISC pilote) | Centre Hospitalier Regional Universitaire De Tours | Phase 2 | Recruiting | France |
| NCT03825835 | 30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants | University of Alberta | Not applicable | Active, not recruiting | Canada, Ireland |
| NCT03424018 | An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia | BioMarin Pharmaceutical | Phase 3 | Active, not recruiting | Australia, Germany, Spain, United Kingdom +2 |
| 2024-512445-17-00 | Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive… | Centre Hospitalier Universitaire De Nimes | Phase 2 | Recruiting | France |
| NCT06881810 | Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment | Central Institute of Mental Health, Mannheim | Phase 2 | Recruiting | Germany |
| NCT06611592 | Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD) | Clinical Academic Center (2CA-Braga) | Phase 2 | Recruiting | Portugal |
| 2023-509679-17-00 | Evaluation of the effect of a single dose of psilocybin on neural correlates of cognitive control in patients… | Centre Hospitalier Universitaire De Nimes | Phase 2 | Active, not recruiting | France |
| 2023-506826-36-00 | A randomized, placebo-controlled, double-blind, 3-period cross-over study in youth with autism spectrum disor… | Oslo University Hospital HF | Phase 2 | Recruiting | Norway |
All areas: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Psychiatry and mental health clinical trials: 7,680 open, 308 in phase 3", https://arcadiumdata.io/clinical-trials/area/psychiatry/, data as of 2026-10-25.